1. Home
  2. FTEL vs KALV Comparison

FTEL vs KALV Comparison

Compare FTEL & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTEL
  • KALV
  • Stock Information
  • Founded
  • FTEL 2007
  • KALV N/A
  • Country
  • FTEL Australia
  • KALV United States
  • Employees
  • FTEL N/A
  • KALV N/A
  • Industry
  • FTEL
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTEL
  • KALV Health Care
  • Exchange
  • FTEL Nasdaq
  • KALV Nasdaq
  • Market Cap
  • FTEL 317.4M
  • KALV 523.1M
  • IPO Year
  • FTEL 2023
  • KALV N/A
  • Fundamental
  • Price
  • FTEL $17.90
  • KALV $12.09
  • Analyst Decision
  • FTEL
  • KALV Strong Buy
  • Analyst Count
  • FTEL 0
  • KALV 4
  • Target Price
  • FTEL N/A
  • KALV $29.00
  • AVG Volume (30 Days)
  • FTEL 76.7K
  • KALV 489.8K
  • Earning Date
  • FTEL 11-01-2024
  • KALV 12-05-2024
  • Dividend Yield
  • FTEL N/A
  • KALV N/A
  • EPS Growth
  • FTEL N/A
  • KALV N/A
  • EPS
  • FTEL N/A
  • KALV N/A
  • Revenue
  • FTEL $3,868,189.00
  • KALV N/A
  • Revenue This Year
  • FTEL N/A
  • KALV N/A
  • Revenue Next Year
  • FTEL N/A
  • KALV $250.03
  • P/E Ratio
  • FTEL N/A
  • KALV N/A
  • Revenue Growth
  • FTEL N/A
  • KALV N/A
  • 52 Week Low
  • FTEL $0.88
  • KALV $7.21
  • 52 Week High
  • FTEL $39.89
  • KALV $16.88
  • Technical
  • Relative Strength Index (RSI)
  • FTEL 55.19
  • KALV 55.89
  • Support Level
  • FTEL $16.48
  • KALV $10.84
  • Resistance Level
  • FTEL $18.40
  • KALV $12.50
  • Average True Range (ATR)
  • FTEL 1.28
  • KALV 0.53
  • MACD
  • FTEL 0.17
  • KALV 0.17
  • Stochastic Oscillator
  • FTEL 84.80
  • KALV 72.97

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Share on Social Networks: